WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C08 CALCIUM CHANNEL BLOCKERS

The calcium channel blockers are classified according to selectivity of calcium channel activity and direct cardiac effects. The ATC 4th levels are subdivided according to chemical structure.

Combinations with ergot alkaloids (C04AE) are classified in this group by using the 50-series.

Combinations with diuretics are classified in C08G.

Combinations with ACE inhibitors are classified in C09BB.

Combinations with beta blocking agents are classified in C07F.

The DDDs for calcium channel blockers are based on the treatment of mild-moderate hypertension, although some are used for other indications (e.g. angina pectoris).

The DDDs for oral and parenteral preparations are equal and are based on the oral dose, since oral preparations represent the major fraction of the total consumption.


C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08CA Dihydropyridine derivatives

Preparations containing nifedipine in combination with ergot alkaloids are classified in C08CA55.
Combinations with diuretics are classified in C08G.

Amlodipine in combination with atorvastatin is classified in C10BX03.


    ATC code  Name  DDD  U Adm.R Note
    C08CA01  amlodipine mg 

List of abbreviations

Last updated: 2013-12-19